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Background: Cystic fibrosis (CF) health care professionals recognize the need to motivate 
people with CF to adhere to nebulizer treatments, yet little is known about how best to achieve 
this. We aimed to produce motivational posters to support nebulizer adherence by using social 
marketing involving people with CF in the development of those posters.
Methods: The Sheffield CF multidisciplinary team produced preliminary ideas that were 
elaborated upon with semi-structured interviews among people with CF to explore barriers and 
facilitators to the use of nebulized therapy. Initial themes and poster designs were refined using 
an online focus group to finalize the poster designs. 
Results: People with CF preferred aspirational posters describing what could be achieved 
through adherence in contrast to posters that highlighted the adverse consequences of nonadher-
ence. A total of 14 posters were produced through this process.
Conclusion: People with CF can be engaged to develop promotional material to support 
adherence, providing a unique perspective differing from that of the CF multidisciplinary team. 
Further research is needed to evaluate the effectiveness of these posters to support nebulizer 
adherence.
Keywords: behavior change, social marketing, patient participation, nebulizers, medication 
adherence
Introduction
Cystic fibrosis (CF) is the most common life-shortening genetic condition in the UK, 
with a population of more than 10,000 affected people.1 Life expectancy for people 
with CF continues to improve,2 with an increasing array of CF treatments being 
introduced.3 Good adherence with CF treatments designed to maintain health is asso-
ciated with better health outcomes and lower treatment costs.4 However, adherence 
with this form of treatment is generally poor, for example, a study among adults with 
CF found that median objective adherence with nebulized treatment is only 36%.5 
Adherence is particularly challenging in CF due to the complex and time-consuming 
nature of effective treatments. Most adherence interventions for CF and other long-
term conditions have also not been effective.6,7
Adherence interventions are inherently complex, and the Medical Research Coun-
cil Guidelines recommend that appropriate evidence and framework should be used 
to inform the development of a complex intervention.8 The Capability, Opportunity 
and Motivation (COM-B) model of behavior is a generic framework to understand 
human behavior, eg, medication adherence, and could assist in providing a theoretical 
underpinning to behavior change interventions.9 The COM-B model intends to be both 
parsimonious and comprehensive. The model hypothesizes that capability, opportunity, 
Correspondence: Martin J Wildman
Adult CF and Respiratory Medicine, 
$GXOW&\VWLF)LEURVLV8QLW&)2IÀFH
Brearley Outpatient, Northern General 
+RVSLWDO+HUULHV5RDG6KHIÀHOG6$8
United Kingdom
Tel ฀+
Email martin.wildman@sth.nhs.uk 
Patient Preference and Adherence 2015:9submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1110
Jones et al
and motivation interact to produce behavior, which in turn 
can feedback to influence these initial components. The 
dynamic nature of this model is illustrated in Figure 1. The 
COM-B model can provide explanations for poor adherence. 
It can also act as a starting point in choosing interventions that 
are most likely to effectively address poor adherence.10 The 
motivation component within the COM-B model comprises 
“those brain processes that energize and direct behavior, not 
just goals and conscious decision making” but also “includes 
habitual processes, emotional responding, as well as analyti-
cal decision making”.9 
The motivational component to medication adherence 
can be further understood with the Necessity-Concerns 
Framework.11 Studies have shown that among intentional 
nonadherers, patients’ beliefs and perceptions about their 
treatment predict adherence.12,13 The Necessity-Concerns 
Framework operationalize the key beliefs that influence 
adherence into beliefs about the necessity of taking the 
medication and concerns about taking it.11
Social marketing has been shown to be effective in behav-
ior change.14 It relies on commercial marketing techniques to 
influence behavior change by altering motivation toward that 
behavior.14 Successful social marketing depends on an under-
standing of the underlying motivations and characteristics 
of the target population.14 “Expert Patients Programme” is a 
Department of Health (DoH) initiative, which complements 
this approach by suggesting that involving patients in design-
ing health care materials is important given their access to sub-
jective expertise otherwise unobtainable to objective health 
professionals.15 A poster is a simple, yet effective, medium 
for displaying a message as part of a social marketing drive.16 
Social marketing posters therefore provide a novel way to 
potentially improve adherence among people with CF.
The aim of this study was to produce a series of social 
marketing posters by using images and concepts refined 
through the utilization of “expert patients”, with the aim that 
in future the posters would result in increased adherence to 
treatment. Another explicit aim of the study was to use the 
process of poster development as a vehicle to carry out 
qualitative work exploring barriers and facilitators of adher-
ence, specifically looking at intentional and unintentional 
nonadherence.
Methods
This study gained ethical approval from the Sheffield Teach-
ing Hospitals NHS Foundation Trust (ref: STH16267) and the 
Regional Ethical Committee (ref: 12/LO/1582). All partici-
pants provided written informed consent prior to taking part 
in the study. There were three stages of data collection.
Stage 1: Initial poster design based  
on literature and input from CF clinicians
Posters were initially designed based on prior literature on 
the barriers to adherence in CF.17–19 Designs were further 
developed using a focus group composed of the Sheffield 
Adult CF multidisciplinary team (MDT). The initial transla-
tion of what was reported in the literature into actual poster 
designs was made possible by accessing the experience 
and knowledge of experienced clinicians. Eighteen posters 
were created and taken to people with CF in the qualitative 
research phase. The posters aimed to motivate adherence by 
creating a discrepancy between a state of nonadherence and 
a better imagined future that would result from increased 
adherence. Participant involvement was split into two stages: 
the individual stage and the focus group stage.
Stage 2: Individual stage
The individual stage consisted of one-to-one sessions between 
a participant and an interviewer for a poster-scoring exercise 
and a semi-structured interview. For the poster-scoring task, 
Ecrcdknkv{
Oqvkxcvkqp
Qrrqtvwpkv{
Dgjcxkqt
Figure 1 The Capability, Opportunity and Motivation (COM-B) model of behavior.
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participants were presented with each poster in a random 
order. Participants rated the posters on a linear scale from 0 
(worst it could be) to 10 (best it could be) for three domains: 
the image, the text, and the overall impact. A semi-structured 
interview was then conducted to elicit participants’ opinions 
about the posters to further improve the design. A semi-
structured interview design was used to obtain in-depth, 
high-quality data without subjecting participants to lengthy 
interviews, allowing the interviewer to guide the discussion 
while allowing participants the freedom to explore sponta-
neously emerging concepts.20 The topic guide for the semi-
structured interview (Supplementary materials) was devised 
in consultation with the Sheffield Adult CF MDT.
Feedback from the individual stage was used to generate 
ideas and refine the initial posters to produce Stage 2 posters, 
including some posters that were completely new.
Stage 3: Focus group stage
Refined posters were then discussed in a focus group with 
quantitative scoring data allowing the omission of posters 
that were universally disliked by participants. 
CF infection control guidelines make conventional face-
to-face focus groups unfeasible. As online focus groups are 
a viable alternative,21 one was therefore conducted using the 
Cisco WebEx Meeting Centre for Internet Explorer Version 
28.7.0.15458 (Cisco Systems Inc., San Jose, CA, USA). 
Participants were able to see the poster designs on their home 
computer while simultaneously discussing the posters via 
conference call. Feedback from the focus group was incorpo-
rated into the final Stage 3 poster designs. Topic guide for the 
focus group interview (Supplementary materials) was devised 
based on experience during the individual stage (Stage 2) and 
in consultation with the Sheffield Adult CF MDT.
Participants
All the participants recruited in this study were under the care 
of the Sheffield Adult CF Unit. Purposive sampling technique 
was performed, whereby participants for the individual stage 
were approached based on their nebulizer adherence to allow 
for a more representative sample. Adherence was calculated by 
comparing electronically recorded data from the participants’ 
adaptive aerosol dispenser device (I-neb®) with their agreed 
treatment regimen. This ensured an equal distribution of low 
(25%), medium (25%–50%), and high adherers (50%), 
ie, four participants for each adherence category. This cat-
egorization of adherence levels takes into account the median 
adherence with nebulized treatment of 36%.5 Recruitment 
continued until data saturation occurred (ie, no new major 
themes emerged from additional participants). A  total of 12 
participants undertook the individual stage of the study, out 
of the approached 36 people with CF. Of the 12 participants, 
eight were females, and the average age was 26.25 years 
(standard deviation [SD] ฀=6.17). Two of the participants had 
completed secondary education (ie, achieved GCSE-equivalent 
qualifications), seven completed college (ie, A-level-equivalent 
qualifications), and three had attained degrees. 
For the focus group, participants were not approached 
based on adherence profile, allowing users of any nebulizer 
type to participate. Participants were ineligible for the focus 
group if they had already completed the individual stage. 
Four participants were able to complete the focus group, 
concordant with previously recommended focus group size 
limits.22 Their average age was 33.75 years SD ฀=5.74, and 
two of the participants were females. A participant had com-
pleted school, two completed college (ie, A-level-equivalent 
qualifications), and one received degree-level education. 
The focus group did not yield any new qualitative data that 
had not already emerged from the semi-structured one-to-
one interviews; hence, only one focus group interview was 
conducted.
Data analysis
Qualitative data from the semi-structured interviews were 
analyzed using inductive content analysis.23 Interviews were 
recorded and transcribed verbatim, before being read and 
listened to independently by authors SJ and NB. A ground-up 
approach was used, whereby the most common concepts 
emerging from the text were independently recorded and 
superordinated by SJ and NB. SJ and NB then collated their 
findings and organized these concepts into a coding manual. 
The coding manual was continuously updated throughout 
the process of analyzing subsequent transcripts through 
regular face-to-face discussion. This process was continued 
until the authors reached a consensus on the final thematic 
structure.
The focus group was again subjected to inductive content 
analysis23 by both SJ and NB independently before reaching 
an agreed consensus. Emergent themes from the focus group 
were used to update the thematic model and posters.
Results
Themes from participants feedback 
about factors associated with nebulizer 
adherence
Two overarching factors derived from the semi-structured 
interviews were personal factors and relationships. These 
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factors were reflected in the following six themes: sense 
of self, personal barriers and drivers, relationship with CF, 
relationship with family/friends, relationship with health care 
professionals, and relationship with wider society. These 
themes are summarized in Figure 2. 
Development of social marketing posters
A key feedback from people with CF during Stage 2 (indi-
vidual stage) resulted in a change to the standard prose 
contained on each poster. The original statements generated 
during Stage 1 (literature search and input from CF clinicians) 
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Qdxkqwun{"kh"vjkpiu"iq"ytqpi"vjgp"o{"ogfkecvkqp"iqgu.
vcmgu"c"uvgr"dcem"dgecwug"K"jcxg"vq"vcmg"ectg"qh"o{
hcokn{0
Xkgykpi"ogfkecn"ugtxkegu"cu"dgkpi"cdng"vq"tguewg"vjg
rcvkgpv"kp"gogtigpekgu"ycu"uckf"vq"tgfweg"oqvkxcvkqp<
Jg"]htkgpf"ykvj"EH_"lwuv"fkf"pqv"fq"cp{vjkpi"cpf"gzrgevgf
vjcv"vjg"jqurkvcn"yqwnf"vtgcv"jko"cpf"dtkpi"jko"dcem"wr
dwv"kv"fkf"pqv"yqtm0
Cnvgtpcvkxgn{."xkgykpi"pgdwnk¦gtu"cu"c"yc{"vq"tgockp
kpfgrgpfgpv"htqo"ogfkecn"ugtxkegu"d{"ockpvckpkpi"{qwt
qyp"jgcnvj"ycu"uggp"cu"c"oqvkxcvqt<
K"vjkpm"kv"mkpf"qh"lwuv"urwtu"{qw"qp"vq"vjkpm"Ð{gcj"K"ecp
fq"vjcv"K"fq"pqv"jcxg"vq"dg"kp"jqurkvcn"cnn"vjg"vkog0Ñ
Rcvkgpvu"rtghgttgf"oqtg"eqnncdqtcvkqp"cpf"kprwv"kpvq"vjgkt
ectg."cpf"vjg"rtgugpeg"qh"vjku"kprwv"ycu"xkgygf"cu"c
oqvkxcvqt0"C"ncem"qh"eqnncdqtcvkqp"qt"cwvqetcvke"uv{ng"ycu
uckf"vq"tgfweg"oqvkxcvkqp"cpf"kpetgcug"hggnkpiu"qh
tgdgnnkqp<
Vjg{"lwuv"vgnn"og"K"pggf"kv"cpf"K"fq"pqv0
Uqog"hgnv"vjcv"dgkpi"oqpkvqtgf"wukpi"gngevtqpke
pgdwnk¦gtu"ycu"c"rqukvkxg"cu"kv"ycu"cdng"vq"xcnkfcvg"vjgkt
ghhqtvu0"Qvjgtu"jqygxgt"hgnv"kv"cp"kpxcukqp"qh"vjgkt"rtkxce{<
Yg"xgt{"owej"jcxg"vq"dtkpi"vjgo"kp"]pgdu_"cpf"rcuu
vjgo"vq"vjg"fgrctvogpv"vq"jcxg"c"nqqm"cv"vjgo"yjkej
hggnu"swkvg"dki"dtqvjgt/kuj0
Vjgog"5<"Tgncvkqpujkr"ykvj"EH
Vjgog"7<"Tgncvkqpujkru"ykvj"ykfgt"uqekgv{
Vjgog"8<"Tgncvkqpujkr"ykvj"hcokn{1htkgpfu
Vjgog"6<"Tgncvkqpujkru"ykvj"rtqhguukqpcnu
Tgncvkqpujkru
Figure 2 Summary of factors associated with nebulizer adherence.
Note: Direct quotes are in italics.
Abbreviation:&)F\VWLFÀEURVLV
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were felt to be too long. The series of statements generated 
by people with CF during Stage 2 were more precise and 
more personal, eg, “reduce your need for hospital admis-
sions”, “avoid intravenous antibiotics”, and “improve your 
lung function”. 
Some participants expressed the desire for fact-based 
posters as they wanted “proof” that nebulizers work. This 
was not the case for everyone, however, with scenarios being 
preferable to facts for some participants. Participants stated 
the need for relatable and attainable concepts to be displayed 
on the posters.
Participants in general preferred messages that empha-
sized aspirations or the positives of adherence as opposed 
to consequences of nonadherence or messages that could be 
perceived as threatening. Messages illustrating this positiv-
ity are given in Table 1. Participants in particular liked the 
message that “prevention works”, which is felt to aid the 
consistency of the different posters. 
In terms of design, participants preferred the posters with 
borders on each side. Curved lines or complex designs were 
said to detract from the message, hence avoided in the final 
poster design.
Participants stated that they would like the posters to be 
placed in clinical rooms. They also asked for personal copies 
in their homes to act as a consistent reminder. 
Ten of the most highly scored posters during Stage 2 
(Figure 3) were then taken forward to Stage 3 (focus group 
stage) for the poster designs to be finalized.
The focus group provided detailed feedback about poster 
design. Feedback supported concepts highlighted in the 
participant interviews during the individual stage (Stage 2). 
Respondents made it clear that posters highlighting that treat-
ment offered a hopeful future were much more effective in 
motivating change than warning posters that highlighted the 
adverse consequences of nonadherence. Having realistic and 
attainable messages were said to be important in making the 
posters applicable to the CF population. 
Some fresh posters were also generated based on the 
suggestions of the focus group. 
Feedback gained from people with CF during both the 
stages (individual stage and focus group stage) was collated 
and fed back to Phillips Respironics to produce the final 
posters. A total of 14 posters were produced (Figure 4).
Discussion
The DoH Expert Patient document emphasizes that the sub-
jective experience of people with long-term chronic health 
conditions can offer expertise, which may differ from health 
professionals.15 In order for social marketing approaches to 
be effective, the designers need to understand their target 
audience.14 By using semi-structured interviews and an online 
focus group, the present study engaged people with CF in 
the research process and was able to gain insight into their 
subjective experience. The data emerging from participants 
therefore informed concepts used in designing the poster, 
making it more relevant. 
Participants with CF are unable to complete face-to-face 
focus groups because of the constraints mandated by infec-
tion control guidelines. An online focus group was therefore 
utilized. A previous study suggested that online focus groups 
offer data comparable to conventional face-to-face methods.21 
We found that online focus group allowed an interactive 
discussion about the posters, and participants were able to 
discuss their own experiences of adherence and motivation, 
generating content-rich data. Coordinating the online focus 
group was straightforward, and the method was universally 
praised by participants. Advancements in software and the 
wide availability of the Internet have now made online focus 
groups relatively straightforward.
The two overarching factors influencing adherence that 
emerged from the qualitative analysis were personal factors 
and relationship. Two main themes were present within per-
sonal factors: the sense of self and personal barriers/drivers. 
The sense of self related to a person’s views and attitudes. The 
individual’s commitment to their treatment could influence 
how important staying healthy was to the individual, which in 
turn could impact the individual’s adherence in the face of a 
difficult treatment regimen. Barriers highlighted in previous 
studies such as other commitments, time pressure, fatigue, 
embarrassment, and views about treatment benefits17–19,24 
were also found to be important to the people with CF in 
the current study who expressed that routine, perceived 
treatment effectiveness, emotions, anxieties, aspirations, and 
future goals could all influence nebulizer adherence. Four 
main themes were present within relationship factors: family 
relationships, relationships with health care professionals, 
relationships with wider society, and the personal relationship 
with CF. These are similar to the themes identified in another 
recent study looking at facilitators and barriers to adherence 
Table 1 Illustrative headlines universally liked by participants
´-DNHZRUNVIXOOWLPHSOD\VJDPHVZLWKKLVPDWHVDQGÀQGVWLPHIRUKLV
nebs
Jane works hard, plays hard  and she does her nebs
A matter of life and breath, using nebs  allows both
Wish you were here? Nebs could get you where you want to be
Note: All these headlines indicated how adherence could impact peoples lives.
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among adolescents with CF.24 It is known that burden of fam-
ily responsibilities could actually lead to reduced adherence 
because of time pressure,24 but family responsibilities could 
also improve adherence by engendering a wish to stay well 
for others. Interaction with the CF MDT team were also 
recognized to impact on adherence, with relationships of 
trust-promoting adherence. If people with CF considered that 
the CF team could rescue them when they were not adhering, 
this could be associated with attitudes that acknowledged 
a decreased need for adherence. The style of engagement 
offered by the CF team influenced adherence. Participants 
preferred having a collaborative relationship allowing patient 
input into care. Participants’ relationships with wider soci-
ety influenced the motivation to adhere. Some participants 
stated that they felt different from others in the society and 
that this could be accompanied by perceptions of stigma, 
leading to a wish to hide CF, which in turn might reduce a 
willingness to carry out treatment away from home. Some 
people with CF perceived that the awareness of CF in the 
general population was poor, which was seen as a cause of 
frustration by some people.
Themes generated from the qualitative data were incor-
porated into the posters. The concept of using posters as part 
of a social marketing approach addresses the motivation 
component of the COM-B model for improving adherence 
and changing behavior. These posters also promote discrep-
ancy between the status quo and a better imagined future, to 
support people with CF to find their own reasons to change. 
This is consistent with the spirit of motivational interviewing 
(MI). MI is a technique suggested to increase the motivation 
of people with CF for treatment by encouraging people to 
make their own choices taking into account positive health 
behaviors and potential consequences, rather than simply 
telling them what they need to do.25 It is hoped that posters 
developed in this way would be particularly helpful in CF 
units setting out to use MI to promote adherence. As such, 
further research is needed to determine the efficacy of these 
social marketing posters to support adherence to treatment 
among people with CF.
Participants with CF in this study preferred the positive 
and supportive nature of posters that described an aspira-
tional future rather than posters that described a future of 
adverse consequences resulting from nonadherence. Previ-
ous research has shown that framing information in terms 
of benefits (gain-framed appeal, which emphasizes the 
benefits of taking action) or detriments (loss-framed appeal, 
which emphasizes the costs of failing to take action) can 
have a substantial influence on the intended behavior. For a 
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health behavior that is perceived to involve some risk of an 
unpleasant outcome, eg, for screening or detection of a health 
problem such as breast self-examination to detect early breast 
cancer, loss-framed appeal is more persuasive.26,27 In contrast, 
gain-framed appeal is more effective in promoting the use of 
“prevention behaviors”, eg, increasing physical activity to 
maintain health status.27,28 Adherence to medication is a pre-
vention behavior to maintain health status; thus, the finding 
that people with CF preferred positive messages to promote 
adherence is congruent with previous research. 
People with CF were enthusiastic in taking part in 
the design of posters to promote adherence. Participants 
in general preferred posters highlighting potential future 
advantages of adherence (gain-frame appeal), but found 
posters highlighting dire consequences of poor adherence 
(loss-frame appeal) to be discouraging. Posters that allow 
people with CF to capture their own reasons for adherence 
may support other efforts, eg, MI to improve adherence. The 
process of incorporating participants’ subjective expertise 
into the project allowed salient concepts to be captured in 
the poster content. Future research is now needed to evaluate 
the effectiveness of this social marketing approach to support 
adherence among people with CF.
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Supplementary materials
Topic guide for the semi-structured 
interview
The research team estimate that this interview schedule would 
take around 1 hour to complete. 
1) As you saw in the ranking exercise we have developed 
posters that aim to motivate or encourage people to use 
their nebulizers regularly. 
a. Can you think of a time that you have lacked moti-
vation to do something even though it needed to be 
done?
 i. What is it about this situation that you particularly 
remember?
b. What was it about this situation that made you feel 
like this?
c. Can you think of a time when you have been very 
motivated to do something?
 i. What is it about this situation that you particularly 
remember?
d. If so, what was it about that situation that made you 
feel that way?
e. How important do you feel motivation actually is? 
 i. In improving peoples health and wellbeing?
 ii. In improving your own health and wellbeing?
2) What are your thoughts about nebulizers?
a. How would you describe the nebulizers you use?
 i. How do you think others find them?
b. How do you feel about the nebulizer you use?
 i. How do you feel about you your nebulizer plan?
 ii. How do you feel about how often you are asked 
to use nebulizers?
c. What impact do nebulizers have on your life?
 i. What impact do you think they may have on other 
people’s lives?
 ii. How does using an I-neb differ from other nebuliz-
ers you may have used in the past?
d. How does your nebulizer compare to your other 
treatments?
e. Are there things that prevent you from using your 
nebulizer? 
 i. What do you think may prevent other people from 
using nebulizers?
f. Are there things that help you to use your 
nebulizer?
 i. What do you think may help other people to use 
their nebulizers?
3) Did you have any thoughts about the posters you have 
seen today?
a. Thinking more specifically about the posters you saw 
today, what were the main things that occurred to you 
when you saw them?
 i. Did any one in particular convey this to you?
b. If yes, which one and why (please pick up poster if 
necessary)?
c. How clear is it that they are about nebulizer use?
 i. Were there any posters in particular that were like 
this?
d. If not clear, how could it be made clearer?
4) What do you think about posters encouraging people to 
use their nebulizers?
a. How successful do you think such posters would be 
in encouraging people to use their nebulizers?
b. How likely would any of these posters be to improve 
your nebulizer use?
 i. How likely would any of these posters be to 
improve other people’s nebulizer use?
c. Where would be the best place to put these posters?
d. If you had the opportunity to design a poster to moti-
vate you to use nebulizers what would your poster 
look like?
 i. Would you make any changes to any of the poster 
you have seen?
e. Are there other methods that would be more 
effective?
5) Is there anything else that you would like to say about 
this project, the posters, or adherence in general?
Topic guide for the focus group interview
Welcome
Hi and welcome to this focus group. First of all let me thank 
you for taking the time to contribute to this research. My 
name is ___________ and I work as ______________. I will 
be running the focus-group today. 
Before we get started I have a brief introduction to explain 
what this focus group is about and what it will involve.
As you may be aware the aim of this focus group is to 
discuss ideas relating to a poster campaign that has been 
developed. The posters relate to nebulized treatment and aim 
to encourage people to use their treatment. 
The posters have been developed by both people with 
cystic fibrosis, and staff who work on the CF ward. Feedback 
we gained from these people has been used to refine and 
improve the posters. 
We are now looking to gain some feedback from you to 
make some final adjustments to the posters before they are 
sent off for publishing. 
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Before we continue I would like to remind you of some 
of the expectations of a focus group in case you have not 
been in one before.  
฀•฀฀ We would like you to be polite and respectful to other 
members of the focus group.
฀•฀฀ While we encourage discussion and debate, please do try to 
not talk over other people. Let people get out their points.
฀•฀฀ We will not tolerate any abusive or foul language directed 
at another in the group. If we judge people to be using this 
form of language they will be ejected from the group.
฀•฀฀  There are no right or wrong answers to these questions 
and we value everyone’s opinion. 
Running order
During this focus-group we will show you a series of posters. 
We will first show you a set of posters and ask you to discuss 
and comment on their message. 
For this we are interested in what you think about the 
message contained in the text, and how effective you feel 
it will be.
We will then ask you to separately comment on the image 
on the posters shown. 
After you have commented on the main text and the 
images of the poster shown we will cycle onto the next set of 
posters and repeat the process. Asking you to first comment 
on the text and message and then the image. 
We will keep repeating this until you have seen all of 
the posters.
Finally we will ask you for your comments on three types 
of poster design. 
Possible general prompt questions
Message
What do you think about the message?
Does the message mean anything to you?
Do you think this message will be effective?
What do you think the aim of the message is?
What does the message make you think about?
Would you change anything about the message?
Is this better/worse than other messages?
Image
What do you think about the image?
Do you feel the image is effective?
Does the image match with the message/text
Would you change anything about the image?
What type of image would work better?
Is this better/worse than other images?
Work Hard Play Hard (slide 1)
The first concept we wish to show is Work Hard, Play Hard. 
What do you think about the message of these posters? Please 
do not comment on the image or the design, we will ask about 
that later. For now please try to only discuss the message.
Possible prompts  message
฀•฀฀ Do you think this is achievable?
฀•฀฀ Do you think this type of message is relatable?
฀•฀฀ What do you think about the message?
฀•฀฀ What do you think about making them gender specific?
Possible prompts  Image
฀•฀฀ Do you like the bright color?
฀•฀฀ What do you think about the images being silhouetted?
฀•฀฀ What do you think about the image focusing on one person?
Life and Breath (slide 2)
Thank you for that, we will now move on to the next set of 
posters – a matter of life and Breath.
Possible prompts  message
฀•฀฀ Is this message accurate?
Possible prompts  image
฀•฀฀ Do you prefer the image where you can see the person, 
or the silhouette?
฀•฀฀ Do you like the idea of their arms being spread?
฀•฀฀ What do you think about the images containing only one 
person?
Works full time (slide 3฀+4฀+5)
(Talk about the message on slides 3, 4, and 5 – then cycle 
back to talk about the image)
Possible prompts  message
฀•฀฀ Is this message attainable?
฀•฀฀ How do you feel about the length of the message? 
฀•฀฀ How do these messages relate to you?
Possible prompts  image
฀•฀฀ How do you feel about the large groups?
฀•฀฀ Do the images relate to you?
฀•฀฀ Which of the four images do you like the most?
Wish you were here (slides 6฀+
Possible prompts message 
฀•฀฀ What does this message mean to you?
฀•฀฀ Do you feel that this message is correct?
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Possible prompts image
฀•฀฀ Which of these images do you prefer? Why?
฀•฀฀ Do you prefer the city-scapes or the other images?
฀•฀฀ How do you feel about there being no people in these 
images?
฀•฀฀ Do you prefer the night time images?
Bugs at bay/kissing without coughing  (slide 8)
This slide contains two posters which are not necessarily 
related. Please try to be clear about which poster you are 
referring to when commenting.
Possible prompts  messages
฀•฀฀ What do you think about these messages?
฀•฀฀ Is kissing without coughing meaningful to you?
฀•฀฀ Is “nebs twice a day” relevant to you?
Possible prompts  images
฀•฀฀ How do you feel about the image in black and white?
฀•฀฀ What do you think is happening in the cartoon picture/
does the cartoon make sense?
฀•฀฀ What do you think about their being a cartoon?
Save your breath  waiting on rescue  (slide 9)
Possible prompts  message
฀•฀฀ Does the message (save your breath) feel like an instruc-
tion?
฀•฀฀ What do you think is meant by rescue?
฀•฀฀ Do you feel that it is right you could take action?
Possible prompts  image
฀•฀฀ What do you feel the tree represents?
฀•฀฀ What do you feel about there being no people in the 
images?
฀•฀฀ What do you think about their being an animal on the 
poster?
฀•฀฀ What do you think about the cat hanging from a rope?
Style  slide 10฀+11฀+12
In these next slides we are going to show you a number 
of poster styles. They will all be of the same message and 
contain the same image. In this section we only want you 
to comment on which designs you like and why. Please 
wait until I have shown you all of the designs before you 
make comment. I will scroll back to the other designs if 
you wish.
Possible prompts
฀•฀฀ Which design is your favorite?
฀•฀฀ Will certain designs fit better with different posters?
฀•฀฀ Can you think of any other designs?
฀•฀฀ How would you design a poster?
Finale
Is there anything else you would like to comment about these 
posters or the project in general?
Thank you for taking part in this focus-group, and we 
hope that you have enjoyed the experience. 
We will be sending an email round again thanking you 
for your participation and it will include a copy of our contact 
details should you wish to make any further comments about 
the posters that you did not want to share in the group.
If you have any questions or would like to talk to some-
one about anything you have mentioned in this focus group, 
please do not hesitate to contact Steve Jones on the contact 
details he has provided. 
